These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 210929)

  • 21. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.
    Brueggemeier RW; Li PK
    Cancer Res; 1988 Dec; 48(23):6808-10. PubMed ID: 3141048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone dependence of 7,12-dimethylbenz[a]anthracene-induced mammary tumor growth: correlation with prostaglandin E2 content.
    Foecking MK; Kibbey WE; Abou-Issa H; Matthews RH; Minton JP
    J Natl Cancer Inst; 1982 Aug; 69(2):443-6. PubMed ID: 6810004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dibutyryl cyclic AMP mimics ovariectomy: nuclear protein phosphorylation in mammary tumor regression.
    Cho-Chung YS; Redler BH
    Science; 1977 Jul; 197(4300):272-5. PubMed ID: 195337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal induction of casein gene expression limited to a small subpopulation of 7,12-dimethylbenz(a)anthracene-induced mammary tumor cells.
    Supowit SC; Rosen JM
    Cancer Res; 1982 Apr; 42(4):1355-60. PubMed ID: 6800652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production.
    Liu SC; Sanfilippo B; Perroteau I; Derynck R; Salomon DS; Kidwell WR
    Mol Endocrinol; 1987 Oct; 1(10):683-92. PubMed ID: 2484711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic adenosine 3':5-monophosphate receptor proteins in hormone-dependent and -independent rat mammary tumors.
    Cho-Chung YS; Clair T; Schwimmer M; Steinberg L; Rego J; Grantham F
    Cancer Res; 1981 May; 41(5):1840-6. PubMed ID: 7214351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory interrelationships for insulin and estrogen action in mammary tumors.
    Hilf R; Hissin PJ; Shafie SM
    Cancer Res; 1978 Nov; 38(11 Pt 2):4076-85. PubMed ID: 100214
    [No Abstract]   [Full Text] [Related]  

  • 28. Androgen effects mediated by estrogen receptor in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Garcia M; Rochefort H
    Cancer Res; 1978 Nov; 38(11 Pt 1):3922-9. PubMed ID: 100211
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclic adenosine 3':5'-monophosphate and protein kinase activity in insulin-dependent and -independent mammary tumors.
    Shafie SM; Cho-Chung YS; Gullino PM
    Cancer Res; 1979 Jul; 39(7 Pt 1):2501-4. PubMed ID: 221106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Estrogen dependent plasminogen activator in breast cancer cells; experimental and clinical studies].
    Yamashita J; Inada K; Matsuo S; Kawano I; Misumi A; Akagi M
    Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1932-8. PubMed ID: 2514343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cAMP-independent protein kinase activity is correlated with growth of rat mammary tumors.
    Sharoni Y; Graziani Y; Karny N; Feldman B; Levy J
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):277-81. PubMed ID: 6323187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
    Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
    Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticarcinogenic effect of retinoids on 7,12-dimethylbenz(a)anthracene-induced mammary tumor induction, and its relationship to cyclic AMP-dependent protein kinase.
    Abou-Issa H; Duruibe VA
    Biochem Biophys Res Commun; 1986 Feb; 135(1):116-23. PubMed ID: 3006676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase of cyclic AMP-dependent protein kinase type II as an early event in hormone-dependent mammary tumor regression.
    Cho-Chung YS; Clair T; Zubialde JP
    Biochem Biophys Res Commun; 1978 Dec; 85(3):1150-5. PubMed ID: 216364
    [No Abstract]   [Full Text] [Related]  

  • 35. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
    Boylan ES; Fowler EH; Wittliff JL
    Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7, 12-dimethylbenz(a)anthracene-induced rat mammary cancer.
    Koibuchi Y; Sugamata N; Iino Y; Yokoe T; Andoh T; Maemura M; Takei H; Horiguchi J; Matsumoto H; Morishita Y
    Int J Mol Med; 1999 Aug; 4(2):145-8. PubMed ID: 10402480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone dependency of rat mammary carcinoma--a comparison of two assay systems.
    Sarkar S; Seshadri R; Shah PN; Kothari LS; Ghosh SN
    Neoplasma; 1979; 26(4):477-82. PubMed ID: 118387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and purification of rat mammary tumor peroxidase.
    DeSombre ER; Lyttle CR
    Cancer Res; 1978 Nov; 38(11 Pt 2):4086-90. PubMed ID: 100215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
    Bradley CJ; Kledzik GS; Meites J
    Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.